{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:25:13Z","timestamp":1774869913250,"version":"3.50.1"},"reference-count":38,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,10,17]],"date-time":"2008-10-17T00:00:00Z","timestamp":1224201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>\n<jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>Myocardial hypertrophy is a common pathological change that accompanies cardiovascular disease. Dopamine D2 receptors have been demonstrated in cardiovascular tissues. However, the pathophysiological involvement of D2 receptors in myocardial hypertrophy is unclear. Therefore, the effects of the D2 receptor agonist bromocriptine and the D2 receptor antagonist haloperidol on angiotensin (Ang) II\u2010 or endothelin (ET)\u20101\u2010induced hypertrophy of cultured neonatal rat ventricular myocytes were investigated in the present study.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Protein content and protein synthesis, determined by examining [<jats:sup>3<\/jats:sup>H]\u2010leucine uptake, were used as estimates of cardiomyocyte hypertrophy. The expression of D2 receptor protein in neonatal rat ventricular myocytes was determined using western blotting. Changes in [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub> in cardiomyocytes were observed by laser scanning confocal microscopy.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Angiotensin II and ET\u20101, both at 10\u00a0nmol\/L, induced myocyte hypertrophy, as demonstrated by increased protein content and synthesis, [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub> levels, protein kinase C (PKC) activity and phosphorylation of extracellular signal\u2010regulated kinase, c\u2010Jun N\u2010terminal kinase and mitogen\u2010activated protein kinase (MAPK) p38 (p38). Concomitant treatment of cells with 10\u00a0nmol\/L AngII plus 10\u00a0\u00b5mol\/L bromocriptine significantly inhibited cardiomyocyte hypertrophy, MAPK phosphorylation and PKC activity in the membrane, as well as [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub> signalling pathways, compared with the effects of AngII alone. In addition, 10\u00a0\u00b5mol\/L bromocriptine significantly inhibited cardiomyocyte hypertrophy induced by 10\u00a0nmol\/L ET\u20101. However, pretreatment with haloperidol (10\u00a0\u00b5mol\/L) had no significant effects on cardiomyocyte hypertrophy induced by either AngII or ET\u20101.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>In conclusion, D2 receptor stimulation inhibits AngII\u2010induced hypertrophy of cultured neonatal rat ventricular myocytes via inhibition of MAPK, PKC and [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub> signalling pathways.<\/jats:p><\/jats:list-item>\n<\/jats:list>\n<\/jats:p>","DOI":"10.1111\/j.1440-1681.2008.05064.x","type":"journal-article","created":{"date-parts":[[2008,10,17]],"date-time":"2008-10-17T09:47:47Z","timestamp":1224236867000},"page":"312-318","source":"Crossref","is-referenced-by-count":17,"title":["DOPAMINE D2 RECEPTOR STIMULATION INHIBITS ANGIOTENSIN II\u2010INDUCED HYPERTROPHY IN CULTURED NEONATAL RAT VENTRICULAR MYOCYTES"],"prefix":"10.1111","volume":"36","author":[{"given":"Hong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi\u2010Hua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya\u2010Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan\u2010Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong\u2010Zhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang\u2010Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,2,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/336783a0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001340051279"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-1931(00)00025-2"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000073676"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-5748(00)00033-2"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.04638.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0330-6"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(00)00208-X"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1998.78.1.189"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(99)00063-9"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2155-04.2004"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81573-1"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199200195-00008"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.2000.1135"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1054\/plef.2000.0148"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)00595-8"},{"key":"e_1_2_6_18_2","first-page":"49","article-title":"Mitogen\u2010activated protein kinase (MAPK) in cardiac tissues","volume":"151","author":"Page C","year":"1996","journal-title":"Mol. Cell. Biochem"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2000.279.4.H1635"},{"key":"e_1_2_6_20_2","first-page":"1373","article-title":"Expression profile of DR1, DR2 protein in rat pathological cardiac hypertrophy","volume":"22","author":"Li H","year":"2006","journal-title":"J. Pathophysiol"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2007.00177.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.87.12.1172"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(72)90094-2"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI13350"},{"key":"e_1_2_6_25_2","first-page":"122","article-title":"Bromocriptine induces regression of left ventricular hypertrophy in peritoneal dialysis patients","volume":"48","author":"Mej\u00eda\u2010Rodr\u00edguez O","year":"2005","journal-title":"Proc. West. Pharmacol. Soc"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026644110737"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(94)90041-8"},{"key":"e_1_2_6_28_2","first-page":"71","article-title":"Dopamine\u2010induced protection against indomethacin\u2010evoked intestinal lesions in rats: Role of anti\u2010intestinal motility mediated by D2 receptors","volume":"9","author":"Miyazawa T","year":"2003","journal-title":"Med. Sci. Monit"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2007.00064.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/bj3470275","article-title":"Specific role of the extracellular signal\u2010regulated kinase pathway in angiotensin II\u2010induced cardiac hypertrophy in vitro","volume":"347","author":"Aoki H","year":"2000","journal-title":"Biochem. J"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-9572(00)00224-0"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011170812267"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.32.6.1054"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-78-3-260"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00926744"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(90)90204-M"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1997.77.2.1003"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00272.2004"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.79.1.137"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2008.05064.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2008.05064.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T02:40:14Z","timestamp":1696905614000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2008.05064.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,25]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1440-1681.2008.05064.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2008.05064.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,25]]}}}